Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06613971 · ClinicalTrials.gov registry record

Dynamic Light Scattering Ocular Measurement in the Detection of Dementia

A clinical trial of Dementia and Dementia Alzheimer Type, sponsored by MD Stem Cells.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06613971 is a study of Dementia and Dementia Alzheimer Type that is actively recruiting participants, run by MD Stem Cells. The registered enrollment target is 50 participants, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06613971, a study of Dementia and Dementia Alzheimer Type, is actively recruiting participants, sponsored by MD Stem Cells.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This is a human clinical study making a noninvasive measurement from a patient's eye to determine whether there is a quantitative difference in measurements between patients with and without the diagnosis of dementia.

Study Locations (1)

Florida

  • 3T Radiology - Coconut Creek

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-04-25
Est. Completion 2028-04-25

Sponsor

MD Stem Cells

3 total trials

What the Registry Record Tells You About NCT06613971

The ClinicalTrials.gov registry entry for NCT06613971 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,723-participant average among 199 other Dementia trials with a reported enrollment target (99% lower). The listed sponsor is MD Stem Cells, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT06613971 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06613971 about?

NCT06613971 is a clinical study titled "Dynamic Light Scattering Ocular Measurement in the Detection of Dementia". This is a human clinical study making a noninvasive measurement from a patient's eye to determine whether there is a quantitative difference in measurements between patients with and without the diagnosis of dementia.

What is the current status of trial NCT06613971?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-04-25. Estimated completion is 2028-04-25.

What conditions does trial NCT06613971 study?

This clinical trial studies the following conditions: Dementia, Dementia Alzheimer Type.

Who is sponsoring clinical trial NCT06613971?

This trial is sponsored by MD Stem Cells, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06613971 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.